VIPLUSMA

Endocyte, Inc.

Application Filed: 2020-01-14

Trademark Application Details

Mark For: VIPLUSMA™ trademark registration is intended to cover the categories of pharmaceutical preparations for the diagnosis and treatment of oncological diseases and disorders; pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products in the treatment of oncological diseases; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals to treat cancer.

Status

2020-01-17 UTC

LIVE APPLICATION Awaiting Examination

The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.

Research	OneLook Acronym Finder
Serial Number	88758608
Mark Literal Elements	VIPLUSMA
Mark Drawing Type	4 - STANDARD CHARACTER MARK
Mark Type	Trademark
Current Location	NEW APPLICATION PROCESSING 2020-01-17
Basis	1(b)
Class Status	ACTIVE
Primary US Classes	006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	No
Intent To Use	Yes
Filed ITU	Yes
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Attorney Name	Frances M. Jagla
Attorney Docket Number	126629.289

Timeline

2020-01-14	Application Filed
2020-01-17	Location: NEW APPLICATION PROCESSING
2020-01-17	Status: Live/Pending
2020-01-17	Status: New application will be assigned to an examining attorney approximately 3 months after filing date.
2020-01-18	Transaction Date

Trademark Parties (Applicants & Owners)

Party:	ENDOCYTE, INC.
Address	3000 Kent Avenue Suite A1-100 West Lafayette, INDIANA UNITED STATES 47906
Legal Entity Type	Corporation
Legal Entity State	DELAWARE

Documents

Drawing	JPEG	2020-01-14
TEAS RF New Application	MULTI	2020-01-14

Attorney of Record

FRANCES M. JAGLA
LANE POWELL PC
1420 FIFTH AVENUE, SUITE 4200
SEATTLE, WA 98101

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	Pharmaceutical preparations for the diagnosis and treatment of oncological diseases and disorders; pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products in the treatment of oncological diseases; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals to treat cancer

Trademark Filing History

Description	Date	Proceeding Number
NEW APPLICATION ENTERED IN TRAM	2020-01-17

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
VIPLUSMA 88758608 not registered Live/Pending	ENDOCYTE, INC. 2020-01-14
VIPLUSMA 79386354 not registered Live/Pending	Novartis AG 2023-11-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.